Literature DB >> 9486289

Influences of melatonin administration on the circulation of women.

A Cagnacci1, S Arangino, M Angiolucci, E Maschio, G B Melis.   

Abstract

The cardiovascular effects induced by the daytime administration of melatonin (1 mg) were compared with those of placebo in 17 young, healthy, early follicular-phase women. Compared with placebo, the administration of melatonin modified, within 90 min, the pulsatility index (PI), evaluated by color Doppler ultrasound, of the internal carotid artery, abdominal aorta, and axillary artery. The effect was linearly related to baseline PI, higher baseline PI being associated with greater PI declines. Melatonin administration significantly decreased mean PI of internal carotid artery (P < 0.02), systolic and diastolic blood pressure (P < 0.01), and norepinephrine levels evaluated after 5 min of standing position (P < 0.02). Heart rate and supine catecholamine levels were not modified. These data indicate that in young, healthy women the administration of 1 mg of melatonin greatly influences artery blood flow, decreases blood pressure, and blunts noradrenergic activation. Clinical implications of present data are worthy to be fully explored.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486289     DOI: 10.1152/ajpregu.1998.274.2.R335

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

1.  Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.

Authors:  R Nonno; M Pannacci; V Lucini; D Angeloni; F Fraschini; B M Stankov
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  The presence and localization of melatonin receptors in the rat aorta.

Authors:  Martin Schepelmann; Lubos Molcan; Hana Uhrova; Michal Zeman; Isabella Ellinger
Journal:  Cell Mol Neurobiol       Date:  2011-06-22       Impact factor: 5.046

3.  Melatonin differentially affects vascular blood flow in humans.

Authors:  Jonathan S Cook; Charity L Sauder; Chester A Ray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-10       Impact factor: 4.733

4.  Melatonin attenuates the vestibulosympathetic but not vestibulocollic reflexes in humans: selective impairment of the utricles.

Authors:  Jonathan S Cook; Chester A Ray
Journal:  J Appl Physiol (1985)       Date:  2010-09-09

5.  Melatonin improves memory acquisition under stress independent of stress hormone release.

Authors:  Ulrike Rimmele; Maria Spillmann; Carmen Bärtschi; Oliver T Wolf; Cora S Weber; Ulrike Ehlert; Petra H Wirtz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

6.  Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans.

Authors:  Chester A Ray
Journal:  J Physiol       Date:  2003-07-17       Impact factor: 5.182

7.  Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.

Authors:  Sayaka Ishigaki; Naro Ohashi; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Masafumi Ono; Yukitoshi Sakao; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2016-01-07       Impact factor: 2.801

8.  Urinary melatonin and risk of incident hypertension among young women.

Authors:  John P Forman; Gary C Curhan; Eva S Schernhammer
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

9.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

10.  Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial.

Authors:  Elizabeth A Green; Bonnie K Black; Italo Biaggioni; Sachin Y Paranjape; Kanika Bagai; Cyndya Shibao; Mirian C Okoye; William D Dupont; David Robertson; Satish R Raj
Journal:  Cardiovasc Ther       Date:  2014-06       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.